2005

1. Has a 3-fold decreased dose of Bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial

   Journal of Urology, Vol. 174, Núm. 4 I, pp. 1242-1247